Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

79 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share as of Q1 2022.
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 45,661,103 shares of 266,212,950 outstanding shares and own 17% of the company stock.
Largest 10 shareholders include Blackstone Inc. (17,985,611 shares), Nantahala Capital Management, LLC (4,346,327 shares), Frazier Life Sciences Management, L.P. (3,746,857 shares), CITADEL ADVISORS LLC (3,512,513 shares), TFG Asset Management GP Ltd (2,825,937 shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1,672,732 shares), FMR LLC (1,642,285 shares), Pendal Group Ltd (1,375,106 shares), Capital World Investors (1,060,579 shares), and JPMORGAN CHASE & CO (799,558 shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.